×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [43]
长春应用化学研究所 [7]
山东大学 [4]
厦门大学 [3]
化学研究所 [3]
大连化学物理研究所 [3]
更多...
内容类型
期刊论文 [83]
会议论文 [1]
发表日期
2021 [2]
2020 [5]
2019 [7]
2018 [8]
2017 [5]
2016 [5]
更多...
学科主题
Biochemist... [1]
Cell Biolo... [1]
Chemistry,... [1]
Chemistry,... [1]
Materials ... [1]
Nanoscienc... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共84条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 9, 页码: 6161-6178
作者:
Xiong, Chaodong
;
Zhou, Lina
;
Tan, Jing
;
Song, Shanshan
;
Bao, Xubin
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2021/08/17
Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance
期刊论文
MEDICAL SCIENCE MONITOR, 2021, 卷号: 27
作者:
Wang, Chunlei
;
Wei, Xiaoyan
;
Shao, Guoliang
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2021/03/15
Carcinoma, Hepatocellular
Docosahexaenoic Acids
Doxorubicin
Nanoparticles
Tuberculosis, Multidrug-Resistant
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7
作者:
Xia, Zong-jun
;
Ji, Yin-chun
;
Sun, De-qiao
;
Peng, Xia
;
Gao, Ying-lei
收藏
  |  
浏览/下载:81/0
  |  
提交时间:2020/12/21
ROS1 kinase
ROS1 inhibitor
SAF-189s
lorlatinib
crizotinib resistance
G2032R mutant
NSCLC
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10
作者:
Zhang, Xiao-tuan
;
Hu, Xiao-bei
;
Wang, Han-lin
;
Kan, Wei-juan
;
Xu, Lei
收藏
  |  
浏览/下载:55/0
  |  
提交时间:2020/12/24
DLBCL
BTK inhibitor
ibrutinib resistance
UPR
TUDCA
2-DG
Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:
Wang, Wen-liang
;
Jiang, Zong-ru
;
Hu, Chen
;
Chen, Cheng
;
Hu, Zhen-quan
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/11/26
PGK1
NG52
kinase inhibitor
Warburg effect
glioma
Fever-Inducible Lipid Nanocomposite for Boosting Cancer Therapy through Synergistic Engineering of a Tumor Microenvironment
期刊论文
ACS APPLIED MATERIALS & INTERFACES, 2020, 卷号: 12
作者:
Qu, Ding
;
Qin, Yue
;
Liu, Yuping
;
Liu, Tingting
;
Liu, Congyan
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2020/10/26
tumor immune microenvironment
fever-inducible nanocomposite
vascular normalization
TAMs reprogramming
breast cancer therapy
Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 189, 页码: 14
作者:
Song, Xiaohan
;
Sun, Pu
;
Wang, Jiang
;
Guo, Wei
;
Wang, Yi
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/07/01
IDO1 inhibitors
Immunotherapy
Anti-Tumor
Semiconducting Nanocomposite with AIEgen-Triggered Enhanced Photoluminescence and Photodegradation for Dual-Modality Tumor Imaging and Therapy
期刊论文
ADVANCED FUNCTIONAL MATERIALS, 2019, 卷号: 29, 期号: 38
作者:
Li, Yawen
;
Liu, Zitong
;
Ma, Yufan
;
Chen, Yuzhi
;
Ma, Kun
收藏
  |  
浏览/下载:81/0
  |  
提交时间:2019/09/30
SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
期刊论文
ACTA PHARMACOLOGICA SINICA, 2019, 卷号: 40, 期号: 7, 页码: 971-979
作者:
Yang, Chang-yong
;
Wang, Lei
;
Sun, Xing
;
Tang, Mi
;
Quan, Hai-tian
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2020/07/01
SHR-A1403
c-Met ADC
anti-tumor
patient-derived xenograft (PDX)
molecular mechanisms
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 8, 页码: 3898-3923
作者:
Liang, Xuewu
;
Zang, Jie
;
Li, Xiaoyang
;
Tang, Shuai
;
Huang, Min
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2020/07/01
©版权所有 ©2017 CSpace - Powered by
CSpace